A bill for an act relating to the definition of medical cannabidiol.

HF 105 updates Iowa's definition of "medical cannabidiol" to explicitly include specific product forms: oral options like tablets and tinctures, topical products such as gels and creams, and limited inhalable forms including vaporized cannabis. This change directly affects patients using medical CBD products and healthcare providers dispensing them under Iowa's medical program. The bill clarifies which cannabis-derived products qualify as "medical cannabidiol" for legal purposes, replacing the previous definition with detailed categories. It does not create new access or alter patient eligibility but ensures defined product types are covered under existing medical use laws. The bill passed committee with strong support (19-1-1) and is now moving forward in the legislative process.